Emsita Trio Forte Tablet ER: A Powerful Trio for Blood Sugar Control

Emsita Trio Forte Tablet ER is a once-daily extended-release combination medication containing Dapagliflozin (10mg), Metformin (1000mg) and Sitagliptin (100mg). This unique formulation provides comprehensive blood sugar control by targeting multiple mechanisms:

* Dapagliflozin: Improves insulin sensitivity, allowing for better glucose uptake by cells.
* Metformin: Reduces hepatic glucose production and promotes peripheral glucose uptake.
* Sitagliptin: Directly inhibits the enzyme responsible for converting food into glucose.

This combined approach makes Emsita Trio Forte a highly effective solution for adults with type 2 diabetes mellitus, helping to lower blood sugar levels, manage weight, and reduce cardiovascular risks. The extended-release formulation ensures consistent and stable blood sugar control throughout the day without frequent dosing.

Consult with your healthcare professional before taking Emsita Trio Forte. This medication is not appropriate for everyone and may interact with other medications.